πŸ‡ΊπŸ‡Έ FDA
Patent

US 9751890

Heteroaryl derivatives as CFTR modulators

granted A61KA61K31/443A61K31/497

Quick answer

US patent 9751890 (Heteroaryl derivatives as CFTR modulators) held by Vertex Pharmaceuticals Incorporated expires Mon Aug 31 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Sep 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 31 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/443, A61K31/497, A61K31/501, A61K31/506